Sumit Bhatnagar

6PUBLICATIONS
12CO-AUTHORS
Haematological tumoursGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsClinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 05, 2025
Model-Informed Paradigm in Drug Development-An End-To-End Case Study From Upadacitinib Development.

Sumit Bhatnagar, Sven Stodtmann, Yuli Qian

|Jul 10, 2024
Pharmacokinetics and Exposure-Response Analyses to Support Dose Selection of Upadacitinib in Crohn's Disease.

Sumit Bhatnagar, Louisa Schlachter, Doerthe Eckert

|Feb 12, 2024
Population pharmacokinetics and exposure-response analyses for efficacy and safety of upadacitinib in patients with axial spondyloarthritis.

Sumit Bhatnagar, Doerthe Eckert, Sven Stodtmann

|Nov 20, 2023
Upadacitinib: Mechanism of action, clinical, and translational science.

Mohamed-Eslam F Mohamed, Sumit Bhatnagar, Julie M Parmentier

|Jan 05, 2021
Dose adjustment of venetoclax when co-administered with posaconazole: clinical drug-drug interaction predictions using a PBPK approach.

Sumit Bhatnagar, Dwaipayan Mukherjee, Ahmed Hamed Salem

Pageof 1